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370Objective: This study compares 2-dimensional, transthoracic echocardiography with cardiac magnetic reso-
nance imaging in the preoperative identification of bicuspid aortic valve before aortic valve surgery.
Methods: Of 1203 patients who underwent an aortic valve operation, 218 had both preoperative transthoracic
echocardiography and cardiac magnetic resonance imaging. Patients in the study group were aged 56 years and
had an ejection fraction of 56%, 76%were male, and 29% had associated coronary artery disease. The results of
transthoracic echocardiography and cardiac magnetic resonance imaging were classified as bicuspid aortic
valve, trileaflet aortic valve, or nondiagnostic. Of the 218 patients, 123 (56%) had bicuspid aortic valve as de-
termined at the time of surgery and 116 (53%) had an ascending aortic aneurysm.
Results: Of the 123 patients with bicuspid aortic valve confirmed at surgery, by transthoracic echocardiography
76 (62%) were identified preoperatively with bicuspid aortic valve, 12 (10%) were misidentified with trileaflet
aortic valve, and 35 (28%) were nondiagnostic for valve morphology. In the same patients with bicuspid aortic
valve, by cardiac magnetic resonance imaging 115 (93%) were identified with bicuspid aortic valve, 5 (4%)
were misidentified with trileaflet aortic valve, and 3 (2%) were nondiagnostic. The difference between transtho-
racic echocardiography and cardiac magnetic resonance imaging to determine the presence of bicuspid aortic
valve was statistically significant (P<.001). In the entire cohort of patients, transthoracic echocardiography
was diagnostic for valve morphology in 155 patients (71%) compared with cardiac magnetic resonance imag-
ing, which was diagnostic in 212 patients (97%) (P<.001).
Conclusions: Cardiac magnetic resonance imaging is more diagnostic than transthoracic echocardiography in
determining the presence of bicuspid aortic valve. A significant factor is the rate of nondiagnostic transthoracic
echocardiography for aortic valvemorphology. Cardiacmagnetic resonance imaging can be performed as a com-
plementary test when transthoracic echocardiography is nondiagnostic for aortic valve morphology. (J Thorac
Cardiovasc Surg 2012;144:370-6)Earn CME credits at
http://cme.ctsnetjournals.org
The prevalence of bicuspid aortic valve (BAV) in the
population is 0.5% to 1.4%.1 Approximately 50% of pa-
tients requiring surgery for aortic stenosis (AS) have
BAV.2 Moreover, patients with BAV have associated aort-
opathy of the ascending aorta, and up to 77% of patients
aged more than 40 years with BAV have associatede Division of Cardiac Surgery,a Division of Cardiology,b and Department of
logy,c Northwestern University, Feinberg School of Medicine, Bluhm Car-
scular Institute at Northwestern Memorial Hospital, Chicago, Ill.
res: Authors have nothing to disclose with regard to commercial support.
d for publicationMay 10, 2011; revisions received July 27, 2011; accepted for
ation Sept 22, 2011; available ahead of print Dec 12, 2011.
for reprints: S. Chris Malaisrie, MD, 201 E Huron St, Galter Pavilion 11-140,
go, IL 60614 (E-mail: cmalaisr@nmh.org).
23/$36.00
ht  2012 by The American Association for Thoracic Surgery
016/j.jtcvs.2011.09.068
The Journal of Thoracic and Cardiovascular Surganeurysmal dilatation.3 Therefore, patients with BAV un-
dergoing aortic valve surgery are typically evaluated for
a coexisting ascending aortic aneurysm because a con-
comitant repair of the ascending aorta should be per-
formed if the diameter of the aorta is greater than
4.5 cm.4 Likewise, patients with known ascending aortic
aneurysm should be evaluated for BAV. Because of the
increased risk of aortic dissection in patients with BAV
compared with patients with normal trileaflet aortic valve
(TAV), a prophylactic repair of an isolated ascending aor-
tic aneurysm is recommended sooner than in patients
with TAV.5 Successful transcatheter aortic valve implan-
tation using self- or balloon-expandable valve stents is
dependent on the shape of the aortic annulus. Asymmet-
ric aortic annuli as seen in patients with BAV are prone to
stent misdeployment and valve distortion.6 Phase III trials
studying transcatheter aortic valve implantation in high-
risk patients with AS in the United States currently ex-
clude patients with BAV.
The preoperative identification of BAV is important in
the management of patients with aortic valve disease orery c August 2012
Abbreviations and Acronyms
AI ¼ aortic insufficiency
AS ¼ aortic stenosis
BAV ¼ bicuspid aortic valve
CMRI ¼ cardiac magnetic resonance imaging
iPAT ¼ integrated parallel acquisition technique
TAV ¼ trileaflet aortic valve
TEE ¼ transesophageal echocardiography
TTE ¼ transthoracic echocardiography
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reliability of 2-dimensional, transthoracic echocardiogra-
phy (TTE) in the preoperative identification of BAV by
using surgical assessment of aortic valve morphology
as the gold standard. In addition, we sought to determine
the utility of cardiac magnetic resonance imaging
(CMRI) as a complementary study to determine valve
morphology.TABLE 1. Characteristics of the 218 patients who underwent an aortic valv
and cardiac magnetic resonance imaging
Characteristics N (%)
BAV
n ¼ 123
Age (y), mean  SD 53.02  13.30
Age range, y 23–82
Male gender 98 (79.7)
NYHA class III/IV 21 (17.1)
EF (%)
Mean  SD
57.60  10.27
Angina 13 (10.6)
Prior MI 2 (1.6)
CAD 24 (20.5)
1-vessel 12 (10.3)
2-vessel 8 (6.8)
3-vessel 4 (3.4)
Left main disease 1 (0.9)
Previous PCI 3 (2.4)
Hypertension 59 (48.0)
Renal failure 3 (2.4)
Hyperlipidemia 59 (48.0)
Chronic lung disease
None 120 (97.6)
Mild 2 (1.6)
Moderate 1 (0.8)
Severe 0 (0.0)
Cerebrovascular disease 5 (4.1)
CVA 0 (0.0)
PVD 1 (0.8)
Marfan syndrome 0 (0.0)
History of atrial fibrillation 6 (4.9)
SD, Standard deviation; NYHA, New York Heart Association; PVD, peripheral vascular dis
CVA, cerebrovascular accident; PCI, percutaneous coronary intervention.
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Study Design
A retrospective chart review of medical records was performed on 1203
patients who underwent an aortic valve operation at the Bluhm Cardiovas-
cular Institute at Northwestern Memorial Hospital between April 2004 and
December 2009. A total of 232 of these patients were identified as having
undergone both preoperative TTE and CMRI. Fourteen patients had TTE
or CMRI performed at other institutions andwere not included in this study,
leaving 218 patients for analysis. This study was approved by the
institutional review board at Northwestern University (project
STU00012288). The institutional review board waived the requirement of
individual patient consent because the analysis was retrospective in nature.
Baseline Characteristics
The characteristics of this study group are summarized in Table 1. Of the
218 patients, 123 (56%) had BAVand 95 (44%) had TAVas determined at
the time of surgery. Morphologic phenotypes of BAV included valves with
2 cusps and no raphe (‘‘purely bicuspid’’) and valves with 2 cusps and 1
raphe (‘‘fused commissure’’).7 Patients with BAV were younger and had
better ejection fraction, less coronary artery disease, less hypertension,
less cerebrovascular disease, and less preoperative atrial fibrillation than
patients with TAV (Table 1). Indications for operation in this study group
included AS in 85 patients (39%), aortic insufficiency (AI) in 56 patients
(26%), mixed AS/AI in 4 patients (2%), and ascending aortic aneurysm ine operation and had both preoperative transthoracic echocardiography
TAV
n ¼ 95
Total
n ¼ 218 P value
60.19  16.30 56.15  15.07 <.001
21–86 21–86
68 (71.6) 166 (76.1) .164
27 (28.7) 48 (22.1) .041
53.61  13.12 55.88  11.73 .017
16 (16.8) 29 (13.3) .176
9 (9.5) 11 (5.1) .011
37 (39.4) 61 (28.9) .003
13 (13.8) 25 (11.9)
8 (8.5) 16 (7.6)
16 (17.0) 20 (9.5)
3 (3.2) 4 (1.9) .326
6 (6.3) 9 (4.1) .183
62 (65.3) 121 (55.5) .011
5 (5.3) 8 (3.7) .300
49 (51.6) 108 (49.5) .597
.090
86 (90.5) 206 (94.5)
5 (5.3) 7 (3.2)
2 (2.1) 3 (1.4)
2 (2.1) 2 (0.9)
10 (10.5) 15 (6.9) .062
6 (6.3) 6 (2.8) .006
7 (7.4) 8 (3.7) .023
6 (6.3) 6 (2.8) .006
14 (14.7) 20 (9.2) .012
ease; EF, ejection fraction; MI, myocardial infarction; CAD, coronary artery disease;
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TABLE 2. Operative indications for the 218 patients in the study
group with delineation of secondary diagnosis when applicable
BAV
n ¼ 123
TAV
n ¼ 95
Total
n ¼ 218 P value
AI 28 (23%) 28 (30%) 56 (26%) .333
Isolated AI 9 19 28
AIþaneurysm 19 9 28
AS 59 (48%) 26 (27%) 85 (39%) .003
Isolated AS 44 26 70
ASþaneurysm 15 0 15
Aortic aneurysm 32 (26%) 41 (43%) 73 (33%) .012
Isolated aneurysm 12 26 38
AneurysmþAS 5 0 5
AneurysmþAI 14 15 29
AneurysmþAS/AI 1 0 1
Mixed AS/AI 4 (3%) 0 (0%) 4 (2%) .206
AI, Aortic insufficiency; AS, aortic stenosis.
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eurysm whether they had BAV or TAV. More patients with BAV had AS
( aneurysm) than did patients with TAV (54% vs 27%, P<.001).Echocardiography Imaging Technique
TTE images were obtained using one of several echocardiography sys-
tems: Sequoia 256 (Siemens Healthcare, Malvern, Pa), Philips Sonos 7500FIGURE 1. In patient Awith bicuspid aortic valve, short-axis views by transtho
were not well visualized and incorrectly identified trileaflet aortic valve. Axial v
(D) open aortic valve correctly identified bicuspid aortic valve.
372 The Journal of Thoracic and Cardiovascular Surgor IE33 (Philips Medical Systems, Andover, Mass), or GE Vivid 7 (GE
Healthcare, Waukesha, Wis). The aortic valve was examined in parasternal
long- and short-axis images. In the parasternal long-axis view, coaptation
off center and unequal leaflet lengths were suggestive of bicuspid valve
anatomy. In the short-axis view, the aortic valve was diagnosed as bicuspid
if only 2 cusps were seen during systole. When a raphe was seen during di-
astole, the diagnosis of bicuspid valve was made if only 2 sinuses were
seen. Ejection fraction was calculated using the biplane method of disks
(modified Simpson’s rule).8
Magnetic Resonance Imaging Technique
CMRI studies were carried out on a 1.5TAvanto (Siemens Healthcare)
with a 12-channel body array coil. The imaging protocol includedmultipla-
nar cine steady-state free precession, phase-contrast imaging, dynamic
time-resolved contrast-enhanced magnetic resonance angiography, and de-
layed enhancement imaging.
Cine steady-state free precession was carried out in multiple short- and
long-axis orientations, including specific right ventricular outflow tract, left
ventricular outflow tract, and aortic valve orientations. The following im-
aging parameters were used: TR/TE 3.2/1.6 ms; flip angle 70 degrees;
bandwidth 800 Hz/pixel; 256 3 256 matrix size; pixel size 2.2 3 1.6
mm2; 6-mm slice thickness; integrated parallel acquisition technique
(iPAT) acceleration factor3 2; acquisition time 5 s/slice; and temporal res-
olution 55 ms/frame.
Phase-contrast magnetic resonance imaging of the aortic valve was
carried out using the following parameters: TR/TE 8/4 ms; flip angle 30 de-
grees; bandwidth: 400 Hz/pixel; 2563 256matrix size; pixel size 2.23 1.6
mm2; 6-mm slice thickness; iPAT acceleration factor3 2; acquisition timeracic echocardiography of (A) closed aortic valve and (B) open aortic valve
iews by cardiac magnetic resonance imaging of (C) closed aortic valve and
ery c August 2012
FIGURE 2. In patient B with bicuspid aortic valve, short-axis views by transthoracic echocardiography of (A) closed aortic valve and (B) open aortic valve
correctly identified bicuspid aortic valve. Axial views by cardiac magnetic resonance imaging of (C) closed aortic valve and (D) open aortic valve incorrectly
identified trileaflet aortic valve.
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cm/s. In-place, phase-contrast magnetic resonance imaging of the right and
left ventricular outflow tracts were obtained with the velocity encoded in the
plane of the slice along the estimated direction of flow.An appropriateveloc-
ity encoding was chosen on the basis of the aortic velocity, which is approx-
imately 100 to 150 cm/s. Orthogonal transaxial slices of the aortic valve
(3 slices per valve) were obtained from the in-plane images.
Time-resolved contrast-enhanced magnetic resonance angiography of
the thoracic aorta was obtained in coronal and sagittal oblique orientations
using a 3-dimensional gradient echocardiography fast low-angle shot pulse
sequencewith the followingparameters: TR/TE1.6/0.8ms; flip angle 30 de-
grees; bandwidth: 900Hz/pixel; 2563 256matrix size; pixel size: 2.03 1.5
mm2; 1.5 to 3.0-mmpartition thickness; iPATacceleration factor32; acqui-
sition time 1 to 3 s/3D set. Echocardiography sharing (ie, TWIST, Siemens
Healthcare) was used to further accelerate the acquisition, and 0.15
mmol/kg of gadolinium-DTPA (Magnevist; Bayer Pharmaceuticas,Wayne,
NJ) was injected at 5 mL/s via an intravenous cannula in the antecubital
fossa in 2 divided doses.
Delayed enhanced imaging was obtained in short- and long-axis orien-
tations using phase-sensitive inversion recovery TurboFLASH (Siemens;
TR/TE 8/4 ms; flip angle 30 degrees; bandwidth: 400 Hz/pixel;
256 3 256 matrix size; pixel size: 2.2 3 1.6 mm2; 6-mm slice thickness;
iPAT acceleration factor 3 2; acquisition time 10 s/slice).
Statistical Analysis
Analysis was performed using standard binary classification, with BAV
designated as the true positive value and TAV as the true negative value toThe Journal of Thoracic and Cameasure sensitivity, specificity, positive predictive value, negative predictive
value, and accuracy. Results classified as nondiagnostic were not applicable
to the statisticalbinarymeasurement and thuswerenotused in the calculations.
Demographic variables and comorbidities were compared between pa-
tients who had BAVand patients who had TAV. Chi-square and Fisher exact
tests were used for categoric variables, and t tests were used for continuous
variables. All statistical analyses were performed using SAS 9.2 statistical
software (SAS Institute Inc, Cary, NC).
A subset of 10 TTE studies and 10 CMRI studies were re-reviewed by an
echocardiographer and CMRI specialist, respectively, to determine inter-
observer reliability with respect to valve morphology. Interobserver reli-
abilities were calculated using the kappa (k) statistic.
RESULTS
Of the 123 patients with BAV confirmed at surgery, by
TTE 76 patients (62%) were identified preoperatively
with BAV, 12 (10%) were misidentified with TAV, and 35
(28%) were nondiagnostic for valve morphology. In the
same patients with BAV, by CMRI 115 (93%) were identi-
fied with BAV, 5 (4%) were misidentified with TAV, and 3
(2%) were nondiagnostic. Examples of concordant and dis-
cordant echocardiography and magnetic resonance imaging
are shown in Figures 1 to 3. The difference between TTE
(Table 3) and CMRI (Table 4) to determine the presence
of BAV was statistically significant (P<.001).rdiovascular Surgery c Volume 144, Number 2 373
FIGURE 3. In patient C with bicuspid aortic valve, short-axis views by transthoracic echocardiography of (A) closed aortic valve and (B) open aortic valve
and axial views by cardiac magnetic resonance imaging of (C) closed aortic valve and (D) open aortic valve both incorrectly identified trileaflet aortic valve.
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aortic valve morphology in 155 patients (71%) compared
with CMRI, which was diagnostic in 212 patients (97%)
(P<.001). Patients were more likely (P<.001) to have a di-
agnostic TTE if the primary indication for operation was not
AS (83%) than if the primary indication was AS (54%)
(Table 5). Likewise, CMRI was more diagnostic in patients
without AS than in patients with AS (100% vs 93%,
P ¼ .01) (Table 6).
By including only diagnostic TTE and CMRI, the accu-
racy of TTE for preoperatively identifying patients with
BAV was 90% (95% CI, 85–95) and the accuracy of
CMRI was 96% (95%CI, 92–98) (P>.05). The sensitivity,
specificity, positive predictive value, and negativeTABLE 3. Classification of findings from transthoracic
echocardiography results for the 218 patients in the study group
TTE
n ¼ 218
BAV (surgery)
n ¼ 123
TAV (surgery)
n ¼ 95
BAV by TTE 76 3
TAV by TTE 12 64
Nondiagnostic 35 28
TTE, Transthoracic echocardiography; BAV, bicuspid aortic valve; TAV, trileaflet
aortic valve.
374 The Journal of Thoracic and Cardiovascular Surgpredictive value on the ability of TTE and CMRI to preop-
eratively identify BAV are summarized in Table 7.
Valve morphology was misidentified in 12 patients by
TTE (Figure 1). Valve morphology was misidentified in 3
patients by CMRI (Figure 2). Two patients were misidenti-
fied by both TTE and CMRI (Figure 3). The likelihood that
both TTE and CMRI incorrectly identified the aortic valve
morphology was 1% (95% CI, 0–2.2).DISCUSSION
Previous studies on the accuracy of 2-dimensional echo-
cardiography in the identification of BAV demonstrated
a 93% accuracy but a 25% rate of nondiagnostic findingsTABLE 4. Classification of findings from cardiac magnetic resonance
imaging results for the 218 patients in the study group
CMRI
n ¼ 218
BAV (surgery)
n ¼ 123
TAV (surgery)
n ¼ 95
BAV by CMRI 115 4
TAV by CMRI 5 88
Nondiagnostic 3 3
CMRI, Cardiac magnetic resonance imaging; BAV, bicuspid aortic valve; TAV, trileaf-
let aortic valve.
ery c August 2012
TABLE 5. Classification of diagnostic and nondiagnostic findings
from transthoracic echocardiography according to primary
operative indication for aortic valve operation as delineated in Table 2
TTE
n ¼ 218 Aortic stenosis
Nonaortic
stenosis Total P value
Diagnostic 48 (54%) 107 (83%) 155 (71%) <.001
Nondiagnostic 41 (46%) 22 (17%) 63 (29%)
TTE, Transthoracic echocardiography.
TABLE 7. Ability of transthoracic echocardiography and cardiac
magnetic resonance imaging to identify bicuspid aortic valve (P>
.05) and accuracy in determining valve morphology by transthoracic
echocardiography and cardiac magnetic resonance imaging (P>.05)
Sensitivity Specificity
Positive
predictive
value
Negative
predictive
value Accuracy
TTE 86% 96% 96% 84% 90%
CMRI 96% 96% 97% 95% 96%
Analysis excludes nondiagnostic tests. TTE, Transthoracic echocardiography; CMRI,
cardiac magnetic resonance imaging.
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phology was attributed to valvular calcifications typical of
patients with AS.10 Likewise, our study demonstrated an ac-
curacy of 90% for TTE but a 29% rate of nondiagnostic
findings, with the majority occurring in patients with AS.
The typical findings of BAV on TTE have remained un-
changed and include fusion of valve cusps, unequal valve
cusp size, and elliptical opening (fishmouth) with 2 com-
missures during systole on the short-axis view.11 The
long-axis view can show an asymmetric cusp closure line,
systolic doming, and cusp prolapse. The current study
confirms that TTE remains the initial study to evaluate the
aortic valve.
One previous study has examined the accuracy of CMRI
in identifying BAV.12 This study, using TTE as the gold
standard, reported an accuracy of 97%. Our results also
showed a high accuracy of 96% using surgical assessment
of the aortic valve as the gold standard. Moreover, CMRI
was diagnostic for valve morphology in more than 97%
of the cases. CMRI is able to obtain cine images, evenly
spaced sequential short time frames, of the full cardiac cy-
cle that allow greater visualization of cardiac function and
morphology when viewed in a cinematic series. With the
use of electrocardiogram gating, cardiac motion can be fro-
zen frame by frame while minimizing artifacts. CMRI can
be a useful complementary study when TTE is nondiagnos-
tic for aortic valve morphology.
The inherent ability of CMRI to perform multiplanar im-
aging is also effective in assessing luminal and mural di-
mensions and changes in the aortic root and thoracic aorta
distal to the aortic root. Moreover, the high degree of accu-
racy with which CMRI provides hemodynamic information
about blood flow changes can be particularly critical in the
diagnosis and evaluation of a coexisting ascending aortic
aneurysm or aortic coarctation in patients with BAV. OurTABLE 6. Classification of diagnostic and nondiagnostic findings
from cardiac magnetic resonance imaging according to primary
operative indication for aortic valve operation as delineated in Table 2
CMRI
n ¼ 218 Aortic stenosis
Nonaortic
stenosis Total P value
Diagnostic 83 (93%) 129 (100%) 212 (97%) .010
Nondiagnostic 6 (7%) 0 (0%) 6 (3%)
CMRI, Cardiac magnetic resonance imaging.
The Journal of Thoracic and Castudy showed that up to 53% of patients with BAV requiring
surgery had an ascending aortic aneurysm. Accurate mea-
surement of aortic diameter is important in surgical indica-
tions for aneurysm replacement. Current guidelines state
that the ascending aorta should be replaced when the diam-
eter is 4.5 cm or greater and aortic valve surgery is also
required.13
Other modalities to identify aortic valve morphology in-
clude transesophageal echocardiography (TEE), real-time
3-dimensional echocardiography, and multidetector com-
puted tomography. Although both TEE and 3-dimensional
echocardiography can provide more detailed imaging, ap-
plication to aortic valve morphology is limited. TEE is an
invasive study, and 3-dimensional echocardiography has
only been shown to be useful in estimating the severity of
AS.14-16 Multidetector computed tomography, similar to
CMRI, has excellent spatial and temporal resolution in
aortic valve imaging and thus may be useful in assessing
the degree of valve calcification. However, patient
exposure to radiation is a consideration. Multidetector
computed tomography is gated only to diastole and
cannot provide information for the full cardiac cycle
without exposing patients to a prohibitively high-risk
amount of radiation, and it provides no information on
hemodynamics.
Study Limitations
Limitations of this study include its retrospective nature.
Although all TTE and CMRI studies were performed and
interpreted at a single center, the reading physician and
technician were not standardized. Because the study in-
cluded echocardiograms acquired more than 7 years ago us-
ing systems of varying ages, image quality in some studies
may have been affected by older technology. In addition,
because it is our protocol to obtain CMRI in patients with
BAV to evaluate the thoracic aorta, a bias toward more non-
diagnostic TTE studies was likely introduced in this study
group. The presence of severe calcification common to
this study group with end-stage aortic valve disease may
have influenced a nondiagnostic diagnosis by TTE and
thus its data on sensitivity. In cases when CMRI was
only performed after inconclusive results from TTE,rdiovascular Surgery c Volume 144, Number 2 375
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however, to minimize any further bias, consistency in the
analysis of subject records and standardization in reporting
data was maintained throughout the study.CONCLUSIONS
Two-dimensional TTE is the initial test obtained in pa-
tients with aortic valve disease. However, aortic valve mor-
phology cannot be determined in a significant number of
patients, particularly patients with AS. CMRI is a useful in-
vestigation for those patients whose aortic valve morphol-
ogy cannot be determined by TTE. In addition, CMRI is
useful in imaging the thoracic aorta in patients with BAV
who may have an associated ascending aortic aneurysm.
Accurate preoperative identification of BAV has implica-
tions in surgical indications for patients with isolated as-
cending aortic aneurysms, surgical management of
coexisting ascending aortic aneurysm during aortic valve
surgery, and patient selection for transcatheter aortic valve
implantation.References
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